Micron Biomedical Extends Series A to $17 million

Funding Rounds

▤ Summary

ATLANTA, GA, Micron Biomedical announced it has secured an additional $3 million investment from J2 Ventures. Micron Biomedical, a life science company developing first-in-class dissolvable microarray-based products that are simplifying and advancing the delivery and administration of drugs and vaccines, today announced it has secured an additional $3 million investment from J2 Ventures, bringing its total Series A funding to $17 million. Announced originally in November 2022, the Series A was led by Global Health Investment Corporation (GHIC) and LTS Lohmann with participation from GRA Venture Fund. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

$ Funding

$
Amount - Total raised
□
Date - Announcement date
◎
Investors Video Island Lead investors
▥
Company - Funded company

▥ Classifications

industries
No industries detected
applications
Business Intelligence

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies